Trade Summary

5 days ago, Talasaz AmirAli, serving as Co-Chief Executive Officer at Guardant Health, Inc. (GH), sold 260,000 shares at $151.20 per share, for a total transaction value of $39,312,654.10. Following this transaction, Talasaz AmirAli now holds 1,881,336 shares of GH.

This sale represents a 12.14% decrease in Talasaz AmirAli's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 30, 2026 at 5:13 PM ET, 4 days after the trade was made.

Guardant Health, Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.